Wait. What!?Did I miss an announcement of a delay on the...

Wait. What!?
Did I miss an announcement of a delay on the estimated timeline?

What I did manage to see was "on target, a few challenges as expected".

Oh and...

“We also achieved an important milestone in our Brain Injury Program with NYR-BI01, our newly improved and highly potent drug candidate crossing the blood-brain-barrier at above therapeutic levels. This means our drug can reach the area of the brain damaged by traumatic brain injury. We are making solid gains in our preparations to evaluate NYR-BI01 in WRAIR’s TBI animal model, which we expect to report on before the end of the year,”